SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.
SOPHiA GENETICS has raised $57.5M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2026.
SOPHiA GENETICS's investors include Hitachi Ventures, Balderton Capital, Perceptive Advisors, Eurazeo, 360 Capital.
SOPHiA GENETICS is headquartered in Boston, United States.
SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.
SOPHiA GENETICS is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SOPHiA GENETICS — Funding & Investors." VCBacked, June 16, 2026, https://www.vcbacked.co/company/sophia-genetics. Accessed September 2, 2026.
VCBacked. (2026). SOPHiA GENETICS — Funding & Investors. Retrieved September 2, 2026, from https://www.vcbacked.co/company/sophia-genetics
{{cite web |title=SOPHiA GENETICS — Funding & Investors |url=https://www.vcbacked.co/company/sophia-genetics |website=VCBacked |access-date=September 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated